2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theSarcopenia Treatment Market?
The escalation in malnutrition levels is projected to spur the expansion of the sarcopenia treatment sector. Malnutrition encompasses deficits, surpluses, or a lack of balance in an individual’s consumption of energy and nutrients, encapsulating both undernutrition along with conditions like obesity, overweight, and diet-related non-transmissible diseases. The role of sarcopenia treatment is to counter the concurrent disorders of malnutrition and sarcopenia in the elderly through strategies like nutritional therapy and physical activities, with the objective to boost muscle mass, fortify strength, and enrich the overall nutritional status. For instance, based on a report released by the World Health Organization (WHO), a United Nations organization situated in Switzerland, in December 2023, malnutrition continues to be a formidable health predicament globally, with a calculated 462 million malnourished individuals and 149 million stunted children under 5 in 2022. Consequently, the escalation in malnutrition is fueling the expansion of the sarcopenia treatment sector.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp
#What Growth Opportunities Will Drive the Sarcopenia Treatment Market’s CAGR Through 2034?
The market for sarcopenia treatment has seen significant growth in the past few years. It is projected to expand from $3.52 billion in 2024 to $3.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors such as an aging population, increased awareness and diagnosis, lifestyle alterations, public health campaigns, and regulatory approvals have contributed greatly to this growth in the historical period.
The market for sarcopenia treatment is predicted to experience substantial growth in the coming years, with projections putting it at $4.72 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.0%. This forecasted expansion during the forthcoming period can be ascribed to factors such as customized medication, nutritional strategies, digital health frameworks, patient enlightenment and empowerment, along with global health campaigns. Key trends anticipated during the forecasted timeline include personalized treatments, the development of new drug categories, the introduction of digital health systems, joint research initiatives, and ongoing research and development.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926
Which Cutting-Edge Market Trends Are Expected to Drive theSarcopenia Treatment Market’s Growth?
Leading businesses that operate within the sarcopenia treatment market are heightening their focus on the innovation of various advanced clinical options. This focus is intended to enhance treatment possibilities. Clinical studies are organized investigations that evaluate the efficacy, safety, and results of medical procedures on human participants. Noteworthy is the announcement from Biophytis, a biotechnology organization based in France, in September 2023 concerning the Food and Drug Administration’s (FDA) endorsement to commence the SARA-31 Phase 3 study in sarcopenia. The study’s objective is to assess the safety and effectiveness of Sarconeos (BIO101) for treating sarcopenic patients who are at risk of motor disability. This research underlines a significant progression in technological and pharmaceutical treatment techniques and provides potential safety and effectiveness improvements for severe sarcopenic patients. This phase 3 study is the first of its kind in sarcopenia and has earned FDA approval. Furthermore, the study will involve approximately 900 sarcopenia patients over the age of 65 with slow walking speed and reduced handgrip strength. The primary goal will be to determine the risk of major mobility disability (MMD), measure walking speed, handgrip strength, and assess patient-reported quality of life.
What Are the Leading Market Players Impacting theSarcopenia Treatment Market’s Growth Trend?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report
How Are the Key Segments of the Sarcopenia Treatment Market Driving Opportunities and Innovations?
The sarcopenia treatment market covered in this report is segmented –
1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theSarcopenia Treatment Market?# Market Expansion?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Sarcopenia Treatment Market 2025, By The Business Research Company:
Mineral And Bone Disorder Treatment Global Market Report 2024
Reversible Airway Diseases Treatment Global Market Report 2024
Urothelial Carcinoma Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
